Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Copenhagen East
-
Copenhagen, Copenhagen East, Denmark, 2100
- The Fertility Clinic, Copenhagen University Hospital, Rigshospitalet
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Endometrioma(s)with a size of 20-70 mm, persisted for at least 3 cycles
- Couples with indication and wish for IVF/ICSI
- Age of women: 20-40 years
- Regular menstrual cycle within normal range (21-35 days)
- Body Mass Index (BMI): 18-30 kg/m2
Exclusion Criteria:
- History with osteoporosis, liver-, kidney- or heart disease or thromboembolic disease
- Treatment of endometriosis with GnRH agonist during the last 3 month
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
|---|
|
size of endometriomas after 2½ month of combined downregulation
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Kristine Lossl, medical doctor, The Fertility Clinic, Copenhagen University Hospital Rigshospitalet
Study record dates
Study Major Dates
Study Start
Study Start
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Endometriosis
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Antineoplastic Agents
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Antineoplastic Agents, Hormonal
- Hormone Antagonists
- Aromatase Inhibitors
- Steroid Synthesis Inhibitors
- Estrogen Antagonists
- Goserelin
- Anastrozole
Other Study ID Numbers
Other Study ID Numbers
- endo 220604
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.